R Squared LTD Arrowhead Pharmaceuticals, Inc. Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, R Squared LTD holds 2,020 shares of ARWR stock, worth $43,490. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,020Holding current value
$43,490% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
90.4MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$338 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$263 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$191 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$137 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$105 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.28B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...